Validating CGM for GDM
NCT: NCT06858787 · RECRUITING
Brief Summary
This is a prospective pilot study to assess the validity of using a continuous glucose monitor (CGM) in diagnosing gestational diabetes mellitus (GDM). Pregnant individuals between the ages of 18-50 years old receiving prenatal care at Mount Sinai Hospital (e..g, E-Level clinic and Faculty Practice Associates) will be enrolled. Potential participants will be approached during their prenatal care appointments. Participants will complete an informed consent form for the study during their standard-of-care prenatal appointments at our institution.
Frequently Asked Questions
What is Validating CGM for GDM?
Validating CGM for GDM is a clinical trial registered under NCT06858787. Current status: RECRUITING.
What is the status of NCT06858787?
The current status of NCT06858787 (Validating CGM for GDM) is: RECRUITING.
When did Validating CGM for GDM start?
Validating CGM for GDM started on 2025-10-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.